Effect of Ap4A, UTP and Salbutamol on Mucociliary Clearance in a Mouse Model of Cystic Fibrosis (in Situ) - Pharmacology & Pharmacy

PP > Vol.4 No.2, April 2013

Effect of Ap₄A, UTP and Salbutamol on Mucociliary Clearance in a Mouse Model of Cystic Fibrosis (in Situ) ()

HTML XML

Download as PDF (Size: 192KB) PP. 176-181

DOI: 10.4236/pp.2013.42025 3,758 Downloads 5,948 Views Citations

Author(s)

Frank Begrow, Eugen J. Verspohl

Affiliation(s)

Department of Pharmacology, Institute of Medicinal Chemistry, University of Muenster, Muenster, Germany.

ABSTRACT

Cystic fibrosis is a life-threatening, wide spread genetic disease diagnosed in 1 to 3000 livebirths of the Caucasian population. Here a mouse model for this disease is described and optimized using the CFTR-channel selective inhibitor CFTR(inh 172). The target parameter was mucociliary clearance measured using microdialysis of the transported fluorescent dye rhodamine in the mouse trachea in situ. The impact of Ap₄A (diadenosine tetraphosphate) as a potential drug was investigated. Its inhalation was effective at low concentrations; established compounds such as Salbutamol and UTP increased mucociliary clearance as well. Our data show a functioning model of cystic fibrosis and the effectiveness of the newly tested Ap₄A.

KEYWORDS

Cystic Fibrosis; Mucociliary Clearance in Situ; Ap₄A; UTP

Share and Cite:

F. Begrow and E. Verspohl, "Effect of Ap₄A, UTP and Salbutamol on Mucociliary Clearance in a Mouse Model of Cystic Fibrosis (in Situ)," Pharmacology & Pharmacy, Vol. 4 No. 2, 2013, pp. 176-181. doi: 10.4236/pp.2013.42025.

Journals Menu

Follow SCIRP

	+1 323-425-8868
	customer@scirp.org
	+86 18163351462(WhatsApp)
	1655362766

	Paper Publishing WeChat

Journals Menu

Home

About SCIRP

Service

Policies